Panacea Biotec Ltd
NSE:PANACEABIO

Watchlist Manager
Panacea Biotec Ltd Logo
Panacea Biotec Ltd
NSE:PANACEABIO
Watchlist
Price: 369.9 INR -2.62% Market Closed
Market Cap: 22.7B INR

Panacea Biotec Ltd
Free Cash Flow

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
TTM
|
See Also

Panacea Biotec Ltd
Free Cash Flow Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Free Cash Flow CAGR 3Y CAGR 5Y CAGR 10Y
Panacea Biotec Ltd
NSE:PANACEABIO
Free Cash Flow
-₹776.7m
CAGR 3-Years
14%
CAGR 5-Years
-16%
CAGR 10-Years
N/A
Transgene Biotek Ltd
BSE:526139
Free Cash Flow
₹12m
CAGR 3-Years
132%
CAGR 5-Years
54%
CAGR 10-Years
N/A
Z
Zenotech Laboratories Ltd
BSE:532039
Free Cash Flow
₹56.3m
CAGR 3-Years
-29%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Hester Biosciences Ltd
NSE:HESTERBIO
Free Cash Flow
₹419m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Biocon Ltd
NSE:BIOCON
Free Cash Flow
₹18B
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
36%
No Stocks Found

Panacea Biotec Ltd
Glance View

Market Cap
22.7B INR
Industry
Biotechnology

Panacea Biotec Ltd. is a biotechnology company, which is engaged in the business of research, development, manufacture, and marketing of vaccines and pharmaceutical formulations. The company is headquartered in New Delhi, Delhi. The Company’s research areas include new chemical entities (NCE), new biological entities (NBE) novel drug delivery system (NDDS) based pharmaceutical formulations, novel peptides and human monoclonal antibodies and vaccine development. The Company’s product portfolio includes pain management, diabetes & cardiovascular management, oncology, renal disease management, osteoporosis management, anti-tubercular, gastrointestinal care products and vaccines. The Company’s subsidiaries include Panacea Biotec Pharma Limited, Panacea Biotec (International) SA, PanEra Biotec Private Limited and Meyten Realtech Private Limited.

PANACEABIO Intrinsic Value
218.45 INR
Overvaluation 41%
Intrinsic Value
Price

See Also

What is Panacea Biotec Ltd's Free Cash Flow?
Free Cash Flow
-776.7m INR

Based on the financial report for Jun 30, 2025, Panacea Biotec Ltd's Free Cash Flow amounts to -776.7m INR.

What is Panacea Biotec Ltd's Free Cash Flow growth rate?
Free Cash Flow CAGR 5Y
-16%

Over the last year, the Free Cash Flow growth was 2%. The average annual Free Cash Flow growth rates for Panacea Biotec Ltd have been 14% over the past three years , -16% over the past five years .

Back to Top